Senator Elizabeth Warren (D-MA) has sent a letter to the Federal Trade Commission asking it to carefully scrutinize CVS Health’s proposed acquisition of Oak Street Health.
ProPublica has published its investigation into Cigna’s system for denying payment for claims as not medically necessary without review by a medical director in order to save itself millions of dollars. The report highlights the experience of one patient for whom Cigna denied payment for a blood test as not medically necessary – even though …
On March 17, 2023, the Centers for Medicare & Medicaid Services issued new guidance for the Independent Dispute Resolution (“IDR”) process under the No Surprises Act for payment determinations made on or after February 6, 2023 for services provided after October 25, 2022. The new guidance was issued in light of federal court decisions striking …
CMS ISSUES NEW GUIDANCE FOR ARBITRATIONS UNDER THE NO SURPRISES ACT Read More »
The Drug Enforcement Administration (“DEA”) has published its long awaited rules on prescriptions of controlled substances via telehealth after the end of the COVID-19 Public Health Emergency (“PHE”). Federal law prohibits the prescription of controlled substances without an in-patient visit unless an exception, such as an established patient relationship, applies. During the PHE, the DEA …
DEA PROPOSES RULES ON TELEHEALTH PRESCRIPTION OF CONTROLLED SUBSTANCES Read More »
The American Hospital Association has submitted comments strongly supporting the Centers for Medicare & Medicaid Services proposed rule changes governing Medicare Advantage plans beginning in the program year 2024. The proposed rule changes would codify CMS guidance that Medicare Advantage plans must follow traditional Medicare’s coverage guidelines and must not make medical necessity determinations based …
The Centers for Medicare & Medicaid Services has ordered an immediate halt to payment decisions by Independent Dispute Resolution (“IDR”) entities under the No Surprises Act as a result of a February 6, 2023 federal court decision vacating the rules governing how out-of-network payment decisions are to be made. In addition, CMS directed IDR entities …
CMS HALTS ARBITRATION PROCESS UNDER THE NO SURPRISES ACT AFTER COURT DECISION Read More »
CVS Health has reported strong full year and fourth quarter 2022 profits and revenues, with its health benefits sector Aetna reporting double-digit revenue growth. CVS reported full year profits of $4.1 billion and full year revenues of $322.5 billion, a 10.4% increase from 2021 revenues of $292.1 billion. CVS also reported strong profits of $2.3 …
CVS HEALTH, WHICH INCLUDES AETNA, REPORTS STRONG FOURTH QUARTER AND FULL YEAR PROFITS Read More »
In a win for providers, the federal court that had previously struck down the sections of the No Surprises Act rules governing how arbitrators determine the amount paid to out-of-network providers, has now struck down the final rules governing these determinations. The rules had been challenged by the Texas Medical Association, one of its physician …
Elevance Health, Inc. (formerly known as Anthem) reported strong full year profits of $8.5 billion for 2022, an increase of 12.9% over the prior year. Elevance’s operating revenues were also sharply up, growing 13.7% over the prior year to $156 billion. As a result, Elevance’s quarterly dividend increased 16% to $148 a share. These results …
The Department of Justice’s Antitrust Division has withdrawn three antitrust policy statements related to enforcement in healthcare markets. The withdrawn policy statements are: Department of Justice and FTC Antitrust Enforcement Policy Statements in the Health Care Area (September 15, 1993) Statements of Antitrust Enforcement Policy in Health Care (August 1, 1996) Statement of Antitrust Enforcement …
DOJ WITHDRAWS THREE ANTITRUST POLICY STATEMENTS RELATED TO HEALTHCARE Read More »